ViiV Healthcare Pty Ltd
Manufacturer / marketing-authorisation holder
ViiV Healthcare Pty Ltd — 42 products across 1 markets, 30 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.
ViiV Healthcare Pty Ltd — 42 productos en 1 mercados, 30 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.
ViiV Healthcare Pty Ltd —— 共 42 个产品，覆盖 1 个市场、30 个品牌名。产品按国家分组；品牌名链到品牌页，成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」，不一定是生产工厂。
42 products · 1 markets · 30 brand names
42 productos · 1 mercados · 30 marcas
42 个产品 · 1 个市场 · 30 个品牌名
Products by country
AU
Source: data-api.health.gov.au
| Brand | Active ingredient(s) | Form |
|---|---|---|
| 3TC | 拉米夫定 | tablet |
| 3TC | 拉米夫定 | liquid |
| 3TC | 拉米夫定 | tablet |
| 3TC lamivudine 10mg/mL oral liquid solution bottle | 拉米夫定 | liquid |
| 3TC lamivudine 150mg tablet bottle | 拉米夫定 | tablet |
| 3TC lamivudine 150mg tablet bottle | 拉米夫定 | tablet |
| APRETUDE cabotegravir (as sodium) 30 mg film coated tablet bottle | Cabotegravir Sodium | tablet |
| APRETUDE cabotegravir 600 mg/3 mL prolonged-release suspension for injection vial | Cabotegravir | injection |
| CABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials | Cabotegravir + Rilpivirine | injection |
| CABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials | Cabotegravir + Rilpivirine | injection |
| CELSENTRI maraviroc 150 mg tablets blister packs | Maraviroc | tablet |
| CELSENTRI maraviroc 150 mg tablets blister packs | Maraviroc | tablet |
| COMBIVIR | 拉米夫定 + 齐多夫定 | tablet |
| COMBIVIR (lamivudine 150mg and zidovudine 300mg) tablet blister pack | 拉米夫定 + 齐多夫定 | tablet |
| Cabenuva | Cabotegravir + Rilpivirine | injection |
| Celsentri 150mg tablets | Maraviroc | tablet |
| Celsentri 150mg tablets | Maraviroc | tablet |
| DOVATO 50/300 dolutegravir (as sodium) 50 mg/lamivudine 300 mg tablet bottle | Dolutegravir Sodium · 拉米夫定 | tablet |
| Dovato | 多替拉韦 + 拉米夫定 | tablet |
| JULUCA dolutegravir (as sodium) 50 mg/ rilpivirine (as hydrochloride) 25 mg tablet bottle | 多替拉韦 · Rilpivirine Hydrochloride | tablet |
| Juluca | 多替拉韦 + Rilpivirine | tablet |
| KIVEXA abacavir 600 mg (as sulfate) and lamivudine 300 mg tablet blister pack | Abacavir Sulfate · 拉米夫定 | tablet |
| RETROVIR | 齐多夫定 | capsule |
| RETROVIR | 齐多夫定 | capsule |
| RETROVIR | 齐多夫定 | liquid |
| RETROVIR syrup zidovudine 50mg/5mL bottle | 齐多夫定 | liquid |
| RETROVIR zidovudine 100mg capsule blister pack | 齐多夫定 | capsule |
| RETROVIR zidovudine 100mg capsule blister pack | 齐多夫定 | capsule |
| RUKOBIA fostemsavir (as trometamol) 600 mg extended release tablet bottle | Fostemsavir Trometamol | tablet |
| TIVICAY PD dolutegravir (as sodium) 5 mg dispersible tablet bottle | Dolutegravir Sodium | tablet |
| TIVICAY dolutegravir (as sodium) 50 mg film-coated tablet bottle | Ingredient not recorded (name-level) | tablet |
| TIVICAY dolutegravir (as sodium) 50 mg film-coated tablet bottle | Dolutegravir Sodium | tablet |
| TIVICAY dolutegravir (as sodium) 50 mg film-coated tablet bottle | Dolutegravir Sodium | tablet |
| TRIUMEQ dolutegravir (as sodium) 50 mg/abacavir (as sulfate) 600 mg/lamivudine 300 mg tablet bottle | Abacavir Sulfate · 多替拉韦 · 拉米夫定 | tablet |
| Tivicay | 多替拉韦 | tablet |
| Triumeq | Abacavir + 多替拉韦 + 拉米夫定 | tablet |
| VOCABRIA cabotegravir (as sodium) 30 mg film-coated tablet, bottle | Cabotegravir | tablet |
| Vocabria | Cabotegravir | tablet |
| ZIAGEN | Abacavir | tablet |
| ZIAGEN | Abacavir | liquid |
| ZIAGEN abacavir (as sulfate) 20mg/mL oral solution bottle | Abacavir Sulfate | liquid |
| ZIAGEN abacavir (as sulfate) 300mg tablet blister pack | Abacavir Sulfate | tablet |